Contact Us

New Stories

• Neuren expands global footprint of landmark Phase 3 trial with Canadian regulatory approval

  December 22, 2025 - - Latest News

• INOVIQ advances exosome-based cancer therapy with promising preclinical results

  December 22, 2025 - - Latest News

• BioMarin’s acquisition of Amicus adds momentum to Dimerix’s Phase 3 kidney candidate

  December 22, 2025 - - Latest News

• Clarity moves toward Phase 3 trial for Cu-64 SARTATE in neuroendocrine tumours

  December 22, 2025 - - Latest News

• Telix strengthens precision medicine strategy with positive Illuccix China Phase 3 results

  December 22, 2025 - - Latest News

• Cleo Diagnostics raises funds to accelerate US launch and advance ovarian cancer screening

  December 18, 2025 - - Latest News

• Actinogen crosses key milestone as pivotal Alzheimer’s trial fully enrols

  December 18, 2025 -